Dr Einar Pontén, CEO

Dr Pontén received his PhD in analytical chemistry at Umeå University, but started 1984 as pharmaceutical analytical chemist at Astra Draco AB i Lund, Sweden. He co-founded and managed the pioneering chromatography company SeQuant AB, that eventually was acquired by Merck KGaA (Darmstadt) in year 2008. Einar was then CEO of Merck SeQuant AB until he returned to business development of academic start-ups in 2012. Einar is also chairman of the board of directors in Biotech i Kungsbacka AB.

LinkedIn profile is here »

Dr Susanne Lindquist

Dr Lindquist received her PhD in microbiology and she has 15 years of research on the bile salt-stimulated lipase (BSSL) enzyme and more than 20 original scientific paper in peer reviewed journals. Susanne has expertise in animal models of arthritis and other inflammatory diseases. She also holds a position as Senior research engineer at Department of Clinical Sciences at Umeå University.

LinkedIn profile is here »